Trials / Completed
CompletedNCT00220233
Olmesartan as an add-on to Amlodipine in Hypertension
Add-on Study of Olmesartan Medoxomil in Patients With Moderate to Severe Hypertension Not Achieving Target Blood Pressure on Amlodipine 5 mg Alone
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 632 (planned)
- Sponsor
- Sankyo Pharma Gmbh · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with amlodipine alone
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olmesartan medoxomil | |
| DRUG | amlodipine | |
| DRUG | hydrochlorothiazide |
Timeline
- Start date
- 2005-04-01
- Completion
- 2007-08-01
- First posted
- 2005-09-22
- Last updated
- 2018-12-24
Locations
5 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00220233. Inclusion in this directory is not an endorsement.